These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2601978)

  • 1. Anti-HIV and anti-HBc antibodies and HBsAg in postmortem blood of drug addicts: the picture for 1988.
    Tappero P; Merlino C; Angeretti A; Cavallo R; Vai S; Negro Ponzi A
    Panminerva Med; 1989; 31(3):137-9. PubMed ID: 2601978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmortem detection of anti-HIV and anti-HBc antibodies in 148 drug addicts died between 1977 and 1987.
    Tappero P; Immormino C; Nebbia F; Ferrara B; Angeretti A; Merlino C; Ponzi AN
    Panminerva Med; 1988; 30(4):243-8. PubMed ID: 3244478
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus serum markers (HBsAg, antiHBs, antiHBc): prevalence among drug addicts in north-east Italy.
    Floreani A; Chiaramonte M; Zago E; Stivanello A; Trivello R; Renzulli G; Naccarato R
    Boll Ist Sieroter Milan; 1981; 60(6):535-7. PubMed ID: 7344722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Examinations for appearance of HCV, HBc and HIV antibodies in patients--addicts visiting the outpatient AIDS clinic for infectious diseases AM in Krakow].
    Caban J; Garlicki A; Dolezal M
    Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):213-4. PubMed ID: 7694264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of hepatitis B virus infection in asymptomatic drug abusers in Malaysia.
    Mangalam S; Tan DS; Vijayamalar B; Collett D; Fang R
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):209-13. PubMed ID: 3787308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
    Smikle MF; Dowe G; Williams EM; Thesiger C
    Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB; Torresi J; Lemoh C; Biggs BA
    J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.